The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CTKB FINANCIAL STATEMENTS

Cytek Biosciences Inc — balance sheet, income statement and cash flow trends

CTKBCytek Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0100 M200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue206.7 M $Gross Profit110 M $ · 53%Operating Income-44.6 M $ · -22%Pre-tax Income-40.8 M $ · -20%Net Income to Owners-80.6 M $ · -39%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue206.7 M $+5.4%
Gross Profit110 M $+3.1%
Operating Income-44.6 M $—
EBITDA-30.1 M $—
Net Income to Owners-80.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets446.9 M
  • Equity322 M $72%
  • Current Liabilities84.3 M $19%
  • Long-term Liabilities40.6 M $9%

Key Figures

YoY change
Total Assets446.9 M $-9.4%
Total Liabilities125 M $+8.0%
Total Equity322 M $-14.7%
Cash & ST Investments262 M $-0.0%
Total Debt26.5 M $+11.7%
Net Debt-47.4 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-20 M020 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-40 M-20 M0-8.8 M $Operating-30.1 M $Investing7.9 M $Financing-31 M $Net Change

Key Figures

YoY change
Operating Cash Flow-8.8 M $-157.7%
Capital Expenditures8.2 M $+98.3%
Free Cash Flow-17 M $-253.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CTKB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.